Preview

Rational Pharmacotherapy in Cardiology

Advanced search

THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS

https://doi.org/10.20996/1819-6446-2010-6-3-306-310

Full Text:

Abstract

Aim. To study the correlation of the renin-angiotensin-aldosterone system (RAAS) activity with the female sex hormone levels and markers of target organ damage in patients with arterial hypertension (HT).

Material and methods. Patients with HT (20 men and 39 postmenopausal women) were involved into the study. The dynamic renal angioscintigraphy and echocardiography were performed, plasma rennin activity (PRA), levels of aldosterone, estradiole and 17-hydroxiprogesterone were determined by radioimmunoassay.

Results. Higher aldosterone level was found in women in comparison with men (212,5±123,9 pg/ml and 148,9±82,5 pg/m, respectively, р=0,03). Negative relations between aldosterone and estradiol levels (r=-0,3; p=0,04), and between aldosterone and 17-hydroxyprogesterone levels (r=-0,318; p=0,04), and positive relations between aldosterone concentration and PRA (r=0,555; p=0,04) was found in women. Besides, correlation between levels of female sex hormones, aldosterone and renal blood flow indicators, glomerular filtration rate, left ventricular mass index (LVMI) were found in women. These correlations were not found in men.

Conclusion. The gender differences of RAAS activity were revealed with higher aldosterone level in postmenopausal hypertensive women in comparison with men. Relationships between PRA, levels of aldosterone and female sex hormones and renal blood flow indices, LVMI were also found in women.

About the Authors

V. I. Podzolkov
Moscow Medical Academy named after I.M. Setchenov
Russian Federation
Bolshaya Pirogovskaya ul. 6, Moscow, 119991


A. E. Bragina
Moscow Medical Academy named after I.M. Setchenov
Russian Federation
Bolshaya Pirogovskaya ul. 6, Moscow, 119991


Ju. N. Rodionova
Moscow Medical Academy named after I.M. Setchenov
Russian Federation
Bolshaya Pirogovskaya ul. 6, Moscow, 119991


E. K. Panferova
Moscow Medical Academy named after I.M. Setchenov
Russian Federation
Bolshaya Pirogovskaya ul. 6, Moscow, 119991


References

1. Шальнова С.А., Баланова Ю.А., Константинов В.В. и др. Артериальная гипертония: распротраненность, осведомленность, прием антигипертензивных препаратов и эффективность лечения среди населения Российской Федерации. Российский кардиологический журнал 2006;4:45-50.

2. Подзолков В.И., Булатов В.А. Ренин-ангиотензин-альдостероновая система как краеугольный камень сердечно-сосудистого и почечного континуума. Органопротективные свойства антагонистов рецепторов к ангиотензину II. Атмосфера. Кардиология 2005;3:20-25.

3. Подзолков В.И., Булатов В.А. Миокард. Нефрон. Взгляд через призму эволюции артериальной гипертензии. РМЖ 2008;16(11):1517-1523.

4. Быстрова М.М., Бритов А.Н. Артериальная гипертония у женщин в постменопаузе. Кардиология 1999;5:72-80.

5. Оганов Р.Г. Эпидемиология артериальной гипертонии в России и возможности профилактики. Тер архив 1997;69(8):66-69.

6. Oparil S., Yiu-Fai Chen Cardiovascular disease in women: overview. In: Stimpel M., Zanchetti A., edi￾tors. Hypertension after menopause. Berlin, New York: Walter de Gruyter;1997. Р.3-19.

7. Маслова Н.П., Баранова Е.И. Гипертоническая болезнь у женщин. СПб: издательство СПбГМУ;2000.

8. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;59(3):551-555.

9. Sulcová J., Hill M., Hampl R., Stárka L. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J Endocrinol 1997;154(1):57-62.

10. Langenickel T., ButtgereitJ., Pagel I. et al.Characterization of an animal model of menopausal hypertension in SHR. Hypertension 2003;43(2):460-463.

11. Jiroutek M.R., Chen M.H., Johnston C.C., Longcope C. Changes in Reproductive Hormones and Sex Hormone-Binding Globulin in a Group of Postmenopausal Women Measured Over 10 Years. Menopause 1998;5(2):90-94.

12. Schriock E.D., Buffington C.K., Givens J.R., BusterJ.E. Enhanced post-receptorinsulin effects in women following dehydroepiandrosterone infusion. J Soc Gynecol Investig 1994;1(1):74-8.

13. Spiegelman B.M., FlierJ.S.Adipogenesis and obesity:rounding outthe big picture. Cell 1996;87(3):377- 389.

14. Suzuki M., Kanazawa A., Hasegawa M. et al. A close association between insulin resistance and dehydroepiandrosterone sulfate in subjects with essential hypertension. EndocrJ 1999;46(4):521-528.

15. CoylewrightM.,ReckelhoffJ.F.,Ouyang P.Menopause and hypertension.An age-old debate.Hypertension 2008;51(4):952-959.

16. Muscelli E., Kozàkovà M., Flyvbjerg A. et al. The Effect of Menopause on Carotid Artery Remodeling, Insulin Sensitivity, and Plasma Adiponectin inHealthy Women.Am JHypertens 2009;22(4):364-370.

17. Munkhaugen J., Lydersen S., Widerøe T.E., Hallan S. Prehypertension, obesity, and risk of kidney dis￾ease: 20-year follow-up of the HUNT I study in Norway. Am J Kidney Dis 2009;54(4):638-646.

18. Wang Y., Chen X., Song Y. et al. Association between obesity and kidney disease: A systematic review and meta-analysis. Kidney Int 2008;73(1):19-33

19. Моисеева О.М., Лясникова Е.А., Семенова Е.Г. и др. Трансформирующий фактор-бета 1 и маркеры активации лейкоцитов при гипертонической болезни. Артериальная гипертензия 2003;9(1):14-16.

20. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006;69(2):213- 217.

21. Gill R.K., Turner R.T., Wronski T.J., Bell N.H. Orchiectomy markedly reduces the concentration of the three isoforms of transforming growth factor beta in rat bone, and reduction is prevented by testosterone. Endocrinology 1998;139(2):546-550.

22. Gibbons G.H., Pratt R.E., Dzau V.J. Vascular smooth muscle cell hypertrophy vs hyperplasia: autocrine transforming growth factor beta 1 expression determines growth response to angiotensin II. J Clin Invest 1992;90(2):456-461.

23. Quehenberger P., Exner M., Sunder-Plassmann R. et al. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res 2002;90(6):711-8.

24. Engeli S., Negrel R., Sharma A.M. Pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000;35(6):1270-1276.

25. Cагинова Е.А., Федорова Е.Ю., Фомин В.В. и др. Формирование поражения почек у больных ожирением. Терапевтический архив 2006; 5: 36-41.

26. James G.D., Sealey J.E., Müller F. et al. Renin Relationship to Sex, Race and Age in Normotensive Population. J Hypertens Suppl 1986;4(5):S387-9.

27. ReckelhoffJ.F. Gender differences in the regulation of blood pressure.Hypertension 2001;37(5):1199- 1208.

28. Шхвацабая И.К., Устинова С.Е., Учитель И.А. и др. Низкорениновая форма гипертонической болезни: особенности функциональных соотношений прессорной системы ренин-альдостерон. Кардиология 1983;23(4):5-10.

29. Karpanou E.A., Vyssoulis G.P., Georgoudi D.G. et al. Ambulatory blood pressure changes in the men￾strual cycle of hypertensive women. Am J Hypertension 1993;6(8):654-659.

30. Schunkert H., Danser A.H., Hense H.W. et al. Effects of estrogen replacement therapy on the renin￾angiotensin system in postmenopausal women. Circulation 1997;95(1):39-45.

31. Vetter H., Zumkley H., Glänzer K. et al. Renin-angiotensin-aldosterone system in essential hyperten￾sion. Inappropriately high plasma aldosterone in young patients with severe hypertension and in old￾er hypertensives. Schweiz Med Wochenschr 1980;110(50):1938-41.

32. Schunkert H., Danser A.H., Hense H.W. et al. Effects of estrogen replacement therapy on the reninangiotensin system in postmenopausal women. Circulation 1997;95(1):39-45.

33. Kaulhausen H., Oehm W., Breuer H. Pattern of renin activity in plasma during the menstrual cycle and in postmenopausal women (author's transl). Klin Wochenschr 1974;52(1):33-8.

34. Karpanou E.A., Vyssoulis G.P., Skoumas J.N. et al. The influence of progressive or abrupt decrease of sex hormones on lipids in hypertensive women (Abstract). Am J Hypertens 1995;8(4 Pt 2):147A.

35. Koren M.J., Devereux R.B., Casale P.N. et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114(5):345- 352.

36. Pines A., Fisman E.Z., Shapira I. et al. Exercise echocardiography in postmenopausal hormone users with mild systemic hypertension. Am J Cardiol 1996;78(12):1385-1389.

37. Klug D., Robert V., Swynghedauw B. Role of mechanical and hormonal factors in cardiac remodeling and biologic limits of myocardial adaptation. Am J Cardiol 1993;71(3):46A-54A.

38. Weber K.T.,JanickiJ.S. Angiotensin and remodelling of the myocardium. Br J Clin Pharmacol 1989;28 Suppl 2:141S-149S.

39. Jalil J.E., Doering C.W., Janicki J.S. et. al. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1989;64(6):1041-1050.

40. Фомина И.Г., Брагина А.Е., Салимжанова Ю.Н. Особенности центральной и почечной гемодинамики у мужчин и женщин в возрасте 40-60 лет, больных гипертонической болезнью. Кардиоваскулярная терапия и профилактика 2007;6(7):5-9.

41. Фомина И.Г., Брагина А.Е., Гайдамакина Н.Е., Салимжанова Ю.Н. Почечная гемодинамика и клубочковая фильтрация у больных гипертонической болезнью в возрасте 40-60 лет. Рациональная Фармакотерапия в Кардиологии 2007;3(5):69-72.

42. Raij L., Keane W.F. Glomerular mesangium: its function and relationship to angiotensin II. Am J Med 1985;79(3C):24-30.

43. Goldsmith S.R. Angiotensin II potentiates the arterial pressure response to volume loading in humans. Am J Hypertens 1994;7(8):767-771.

44. Palmer B.F. Impaired renal autoregulation: implications forthe genesis of hypertension and hypertensioninduced renal injury. Am J Med Sci 2001;321(6):388-400.

45. Brown N.J., Vaughan D.E., Fogo A.B. Aldosterone and PAI-1: implications for renal injury. J Nephrol 2002;15(3):230-235.

46. Epstein M. Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications. Am J Kidney Dis 2001;37(4):677-88.


For citation:


Podzolkov V.I., Bragina A.E., Rodionova J.N., Panferova E.K. THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS. Rational Pharmacotherapy in Cardiology. 2010;6(3):306-310. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-3-306-310

Views: 310


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)